CClinicalTrials.gg
CompletedNCT05545709Updated Sep 21, 2022

5G-based Telerobot-assisted Spine Surgery

An observational study in Surgery, sponsored by Beijing Jishuitan Hospital. Completed at 1 site in China. Per ClinicalTrials.gov, last updated 2022-09-21.

Sponsored by Beijing Jishuitan Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
192
Sex
All
01

Study summary

This study retrospectively analyzed cases of remote robot-assisted spine surgery performed jointly by the Beijing Jishuitan Hospital Spinal Surgery and partner hospitals, with cases of local orthopedic robot-assisted spine surgeries performed by Beijing Jishuitan Hospital between April 2021 and December 2021.

Read the detailed description

Local orthopedic robot-assisted spine surgeries were performed according to the guidelines for thoracolumbar pedicle screw placement assisted by orthopedic surgical robots.

Based on the 5G network, the orthopedic robotic remote surgery platform is built at Beijing Jishuitan Hospital, providing primary hospitals with a platform for preoperative consultation, intraoperative communication and surgical robot teleoperation, and postoperative follow-up. With the support of the 5G network, equipment and surgical robots are integrated into the remote surgery service platform, building a high-speed transmission channel between Beijing Jishuitan Hospital and other hospitals.

02

Conditions studied

  • Surgery
03

In context

Lead sponsor

Beijing Jishuitan Hospital is the lead sponsor of 43 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients accepted robot-assisted spine surgery

Inclusion criteria

  • patients received remote robot-assisted spinal surgery or local orthopedic robot-assisted spinal surgery;
  • patients had complete medical records and imaging data;
  • patients provided informed consent.

Exclusion criteria

Exclusion Criteria:

  • revision surgery;
  • more than four surgical segments;
  • patients with severe comorbidities.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
192 participants (actual)
Patient registry
No

Groups and cohorts

  • remote group

    Based on the 5G network, the orthopedic robotic remote surgery platform is built at Beijing Jishuitan Hospital, providing primary hospitals with a platform for preoperative consultation, intraoperative communication and surgical robot teleoperation, and postoperative follow-up. With the support of the 5G network, equipment and surgical robots are integrated into the remote surgery service platform, building a high-speed transmission channel between Beijing Jishuitan Hospital and other hospitals.

    Procedure: remote robot-assisted spine surgery

  • local group

    Local orthopedic robot-assisted spine surgeries were performed according to the guidelines for thoracolumbar pedicle screw placement assisted by orthopedic surgical robots.

Interventions

  • Procedureremote robot-assisted spine surgery

    Based on the 5G network, the orthopedic robotic remote surgery platform is built at Beijing Jishuitan Hospital, providing primary hospitals with a platform for preoperative consultation, intraoperative communication and surgical robot teleoperation, and postoperative follow-up. With the support of the 5G network, equipment and surgical robots are integrated into the remote surgery service platform, building a high-speed transmission channel between Beijing Jishuitan Hospital and other hospitals.

06

What researchers measure

Primary outcomes

  1. The accuracy of guide-wire placement or positioning

    according to the Gertzbein and Robbins scale, including grade A (screw was completely within the pedicle), grade B (pedicle cortical breach \<2 mm), grade C (pedicle cortical breach \<4 mm), grade D (pedicle cortical breach \<6 mm), and grade E (pedicle cortical breach \>6 mm).

    Time frame: 1 month

Secondary outcomes

  1. operation time

    Time from start to finish of surgery

    Time frame: 1 day

  2. complication

    Nerve injury, epidural hematoma, and infection

    Time frame: 1 month

  3. network interruptions

    failure to establish connection, the interruption of connection and severe delays in connection, and remote surgery abandonment.

    Time frame: 1 day

07

Study locations

1 site
  • Beijing Jishuitan hospital
    Beijing, Beijing 100000, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05545709
Lead sponsor
Beijing Jishuitan Hospital
Responsible party
Wei Tian (Clinical Professor, Beijing Jishuitan Hospital) — Principal investigator
First posted
Sep 19, 2022
Start date
Apr 1, 2021
Primary completion
Dec 31, 2021
Completion
Jul 1, 2022
Last update
Sep 21, 2022

Study contacts

Wei Tian
principal investigator · Beijing Jishuitan Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion